PinkDx

PinkDx

Private
Daly City, CaliforniaHealthcare & Life Scienceswww.pinkdx.com

Last Round

Series A

Extension

Jan 23, 2025

Total Funding Raised

$45M

Momentum Score

75 /100

Company Overview

PinkDx is a healthcare company focused on enhancing women's health by developing molecular tests that offer non-invasive alternatives for diagnosing vague gynecological cancer symptoms, thereby providing timely and impactful answers for women.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gynecological cancer testmolecular diagnosticsnon-invasive testwomen's healthliquid biopsyfemtechcancer detectionRNA-based diagnosticsdiagnostics companyprecision medicinemulti-omic platformOB/GYN diagnosticsB2B2C healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PinkDx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PinkDx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 23, 2025
Series AApr 25, 2024

Key People

Founding team and executive leadership

Giulia Kennedy

Co-Founder And Chief Scientific Officer

Founding Team

PinkDx Investors

Notable investors and investment history

InvestorRounds
The Production BoardSeries A Extension, Series A
BEVCSeries A Extension
Catalio Capital ManagementSeries A, Series A Extension
Byers CapitalSeries A Extension, Series A
Blue Cross Blue Shield Venture PartnersSeries A Extension
Sandbox Clinical Ventures FundSeries A Extension
Mountain Group PartnersSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Grew 19% QoQ, from 31 to 37 employees.

  • Jan 23, 2025

    $5M round completed.

PinkDx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PinkDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PinkDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersDaly City, California
Employee Range37
Year Founded2022
Last FundingJan 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.